This SuperSeries is composed of the SubSeries listed below.
HDAC inhibitors are thought to regulate gene expression by post-translational modification of histone as well as non-histone proteins. Often studied at single loci, increased histone acetylation is the paradigmatic mechanism of action, however, little is known of the extent of genome-wide changes of the mammalian genome when stimulated by the hydroxamic acids, TSA and SAHA. In primary human vascular endothelial cells we map the chromatin modifications, histone H3 acetylation of lysine 9 and 14 (H3K9/14ac) using chromatin immunoprecipitation (ChIP) coupled with massive parallel sequencing (ChIP-seq). Since acetylation mediated gene expression is often associated with modification of other lysine residues we also examined H3K4me3 and H3K9me3 as well as changes in CpG methylation (CpG-seq).
More...This SuperSeries is composed of the SubSeries listed below.
HDAC inhibitors are thought to regulate gene expression by post-translational modification of histone as well as non-histone proteins. Often studied at single loci, increased histone acetylation is the paradigmatic mechanism of action, however, little is known of the extent of genome-wide changes of the mammalian genome when stimulated by the hydroxamic acids, TSA and SAHA. In primary human vascular endothelial cells we map the chromatin modifications, histone H3 acetylation of lysine 9 and 14 (H3K9/14ac) using chromatin immunoprecipitation (ChIP) coupled with massive parallel sequencing (ChIP-seq). Since acetylation mediated gene expression is often associated with modification of other lysine residues we also examined H3K4me3 and H3K9me3 as well as changes in CpG methylation (CpG-seq). Genome-wide mRNA sequencing indicates the differential expression of about 30% of genes, with almost equal numbers being up- and down- regulated. We observe deacetylation conferred by TSA and SAHA that are associated with decreased gene expression. Histone deacetylation is associated with the loss of p300/CBP binding at gene promoters. This study provides an important framework for HDAC inhibitor function in vascular biology and a comprehensive description of genome-wide deacetylation.
Overall design: Refer to individual Series
Less...| Accession | PRJNA159705; GEO: GSE37378 |
| Type | Umbrella project |
| Publications | - Rafehi H et al., "HDAC Inhibition in Vascular Endothelial Cells Regulates the Expression of ncRNAs.", Noncoding RNA, 2016 May 25;2(2)
- Rafehi H et al., "Vascular histone deacetylation by pharmacological HDAC inhibition.", Genome Res, 2014 Aug;24(8):1271-84
|
| Submission | Registration date: 18-Apr-2012 Human Epigenetics, Diabetes, Monash University Central Clinical School |
| Relevance | Superseries |
Project Data:
| Resource Name | Number of Links |
|---|
| Sequence data |
| SRA Experiments | 65 |
| Publications |
| PubMed | 3 |
| PMC | 3 |
| Other datasets |
| BioSample | 65 |
| GEO DataSets | 7 |
Vascular histone deacetylation by pharmacological HDAC inhibition encompasses the following 6 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 4 |
BioProject accession | Organism | Title |
|---|
| PRJNA159809 | Homo sapiens | Vascular histone deacetylation by pharmacological HDAC inhibition [TSA, ChIP-seq] (Human Epigenetics, Diabetes,...) | | PRJNA238014 | Homo sapiens | Vascular histone deacetylation by pharmacological HDAC inhibition [TSA, MBD-seq] (Human Epigenetics, Diabetes,...) | | PRJNA238015 | Homo sapiens | Vascular histone deacetylation by pharmacological HDAC inhibition [SAHA, ChIP-seq] (Human Epigenetics, Diabetes,...) | | PRJNA238016 | Mus musculus | Vascular histone deacetylation by pharmacological HDAC inhibition [TSA, mouse, ChIP-seq] (Human Epigenetics, Diabetes,...) |
|
| Transcriptome or Gene expression | 2 |
BioProject accession | Organism | Title |
|---|
| PRJNA159807 | Homo sapiens | Vascular histone deacetylation by pharmacological HDAC inhibition [TSA, RNA-seq] (Human Epigenetics, Diabetes,...) | | PRJNA238012 | Homo sapiens | Vascular histone deacetylation by pharmacological HDAC inhibition [SAHA, RNA-seq] (Human Epigenetics, Diabetes,...) |
|